Literature DB >> 30797956

Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential.

Vibhuti Agrahari1, Pierre-Alain Burnouf2, Thierry Burnouf3, Vivek Agrahari4.   

Abstract

Nanocarriers (synthetic/cell-based have attracted enormous interest for various therapeutic indications, including neurodegenerative disorders. A broader understanding of the impact of nanomedicines design is now required to enhance their translational potential. Nanoformulations in vivo journey is significantly affected by their physicochemical properties including the size, shape, hydrophobicity, elasticity, and surface charge/chemistry/morphology, which play a role as an interface with the biological environment. Understanding protein corona formation is crucial in characterizing nanocarriers and evaluating their interactions with biological systems. In this review, the types and properties of the brain-targeted nanocarriers are discussed. The biological factors and nanocarriers properties affecting their in vivo behavior are elaborated. The compositional description of cell culture and biological matrices, including proteins potentially relevant to protein corona built-up on nanoformulation especially for brain administration, is provided. Analytical techniques of characterizing nanocarriers in complex matrices, their advantages, limitations, and implementation challenges in industrial GMP environment are discussed. The uses of orthogonal complementary characterization approaches of nanocarriers are also covered.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biological proteins; Blood-brain barrier; Cell-based nanocarriers, Neurodegenerative disorders; Cell-culture media; Characterization methods; Nanoparticles; Physicochemical properties; Protein-corona

Year:  2019        PMID: 30797956     DOI: 10.1016/j.addr.2019.02.008

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  14 in total

Review 1.  Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function.

Authors:  Rebecca L Pinals; Linda Chio; Francis Ledesma; Markita P Landry
Journal:  Analyst       Date:  2020-07-01       Impact factor: 4.616

2.  mTORC1/rpS6 signaling complex modifies BTB transport function: an in vivo study using the adjudin model.

Authors:  Ming Yan; Linxi Li; Baiping Mao; Huitao Li; Stephen Y T Li; Dolores Mruk; Bruno Silvestrini; Qingquan Lian; Renshan Ge; C Yan Cheng
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-05-21       Impact factor: 4.310

Review 3.  Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery.

Authors:  Yu Wu; Miora Rakotoarisoa; Borislav Angelov; Yuru Deng; Angelina Angelova
Journal:  Nanomaterials (Basel)       Date:  2022-06-30       Impact factor: 5.719

Review 4.  Prospects of biological and synthetic pharmacotherapies for glioblastoma.

Authors:  David B Altshuler; Padma Kadiyala; Felipe J Nuñez; Fernando M Nuñez; Stephen Carney; Mahmoud S Alghamri; Maria B Garcia-Fabiani; Antonela S Asad; Alejandro J Nicola Candia; Marianela Candolfi; Joerg Lahann; James J Moon; Anna Schwendeman; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Biol Ther       Date:  2020-01-20       Impact factor: 4.388

5.  PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers.

Authors:  Ge Jiang; Huanhuan Jia; Jindi Qiu; Junfeng Ban; Zhenjie Mo; Yifeng Wen; Yan Zhang; Yuqin Wen; Qingchun Xie; Zhufen Lu; Yanzhong Chen; Hao Wu; Qingchun Ni; Fohua Chen; Jiashu Lu; Zhijiong Wang; Haoting Li; Junming Chen
Journal:  Int J Nanomedicine       Date:  2020-11-24

Review 6.  Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating Animal Studies.

Authors:  Syed Abdullah Alkaff; Krishna Radhakrishnan; Anu Maashaa Nedumaran; Ping Liao; Bertrand Czarny
Journal:  Int J Nanomedicine       Date:  2020-01-21

Review 7.  Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.

Authors:  Thierry Burnouf; Vibhuti Agrahari; Vivek Agrahari
Journal:  Int J Nanomedicine       Date:  2019-11-12

Review 8.  Advancement of nanomedicines in chronic inflammatory disorders.

Authors:  Vikas Jogpal; Mohit Sanduja; Rohit Dutt; Vandana Garg
Journal:  Inflammopharmacology       Date:  2022-02-25       Impact factor: 5.093

Review 9.  Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence.

Authors:  Samar Zuhair Alshawwa; Abeer Ahmed Kassem; Ragwa Mohamed Farid; Shaimaa Khamis Mostafa; Gihan Salah Labib
Journal:  Pharmaceutics       Date:  2022-04-18       Impact factor: 6.525

10.  Human platelet lysate biotherapy for traumatic brain injury: preclinical assessment.

Authors:  Ouada Nebie; Kevin Carvalho; Lassina Barro; Liling Delila; Emilie Faivre; Ting-Yi Renn; Ming-Li Chou; Yu-Wen Wu; Ariunjargal Nyam-Erdene; Szu-Yi Chou; Luc Buée; Chaur-Jong Hu; Chih-Wei Peng; David Devos; David Blum; Thierry Burnouf
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.